s3 efficacy endpoints in oncology
Published 5 months ago • 264 plays • Length 39:47Download video MP4
Download video MP3
Similar videos
-
6:07
introduction to endpoints in oncology clinical trials
-
42:31
overview of the european medicines agency (ema), part 1 of 3
-
1:00
act now: transition your clinical trials to ctis | important information for clinical trial sponsors
-
11:11
lecture medical oncology - endpoints in clinical trials
-
2:01
clinical trials in the eu - en version
-
4:28
krebs - deshalb kämpfe ich nicht!
-
34:21
phase i clinical trials: objectives, design, and endpoints
-
17:19
nitrosamines impurities by m. filancia (ema)
-
3:18
updated standardized definitions for efficacy end points in adjuvant breast cancer clinical trials
-
7:34
marketing authorization application accepted by european medicines agency for zolbetuximab
-
1:04
european medicines agency (ema) member countries
-
42:19
g4 propaedeutic for benefit-risk assessment
-
0:14
clinical research: phase 1 clinical trials
-
2:28
what is the chmp?
-
1:46
what is the european medicines agency (ema)? what is its role?
-
1:02:39
assessing treatment efficacy in early-phase oncology trials
-
0:31
clinical trials in the eu - short version
-
4:13
primary and secondary endpoints in a clinical trial: what are they? #myeloma
-
0:33
use facts and science when deciding on vaccination
-
1:03
the medicines adaptive pathways to patients (mapps) and its importance in oncology
-
18:40
use of surrogate endpoints in oncology